Last updated on April 20, 2014 at 8:28 EDT

Elsevier Appoints New President of Elsevier CPM Resource Center

April 29, 2012

GRAND RAPIDS, Michigan, April 30, 2012 /PRNewswire/ –

Hajo Oltmanns to lead expansion of CPM’s clinical decision support tools

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and services, has appointed Hajo Oltmanns as the new
President of Elsevier CPM Resource Center [http://www.cpmrc.com ] (CPM), a leader in
developing clinical decision support (CDS) tools for healthcare.

Hajo will lead the continued development and expansion of CPM’s clinical decision
support tools and the engagement of the CPM International Consortium, an organization
composed of hundreds of CPM’s client hospitals and health systems. Hajo is also
responsible for the development of Elsevier’s new Order Sets, which is expected to launch
in late 2012.

Hajo’s appointment comes as CPM and our other CDS
[http://www.clinicaldecisionsupport.com ] groups work together to transform healthcare,”
said Jay Katzen, Managing Director, Elsevier Clinical Decision Support and Payer
Solutions. “Hajo’s experience and understanding of healthcare will help grow this
business, empowering our customers to achieve measureable, sustainable success through the
implementation of evidence-based CDS and professional practice expertise.”

At Elsevier Health Sciences, Hajo previously served as the Senior Vice President of
Strategy & Business Development, focusing on the CDS group. Hajo joined Elsevier in 2007
and served as a member of the executive strategy team, working across all international
businesses units while based in Amsterdam.

Prior to Elsevier, Hajo was a manager at the Boston Consulting Group in Chicago, where
he focused on strategy, development and customer understanding across several industries,
including healthcare.

Originally from Germany, Hajo has an MA from the University of Edinburgh and an MBA
from Northwestern University’s Kellogg School of Management.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact
        Tom Reller
        Vice President, Global Corporate Relations, Elsevier

SOURCE Elsevier

Source: PR Newswire